Joseph Lex, MD, FACEP, FAAEM

• Associate Professor
• Department of Emergency Medicine
• Temple University School of Medicine
• Philadelphia, Pennsylvania

In a murine model of Yersinia pestis necrotizing pneumonic plague whey protein causes erectile dysfunction 20 mg tadora with mastercard, neutrophil ablation led to an increase in bacterial colonies following 24 h of exposure doctor who cures erectile dysfunction purchase tadora discount. Additionally erectile dysfunction and diabetes medications best order for tadora, it was observed that the addition of human neutrophils (but not other peripheral blood mononuclear cells) to in vitro cultures decreased Yersinia pestis colony numbers by fivefold (Laws et al erectile dysfunction treatment center 20 mg tadora fast delivery. The role of the neutrophil in bacterial and fungal pathogenesis is well characterized tobacco causes erectile dysfunction purchase genuine tadora on-line, but its role in viral pathogenesis is not yet fully elucidated. While one study reported that a decrease in neutrophil count prior to influenza A infection resulted in higher mortality rates in mice, another study reported that excessive lung neutrophilia during influenza infection resulted in acute lung inflammation, suggesting that a balance is important to ensure host protection without causing collateral tissue damage (Urban et al. Driscoll and Schlesinger reported that exposure of alveolar macrophages to ozone in vitro stimulated neutrophil chemotactic mediator release (Driscoll et al. Macrophages originate from bone marrow-derived monocytes that differentiate following entry into the tissues and have been classified as M1 or M2, modeled after the Th1/Th2 classification scheme for T cells, based on inflammatory involvement (Balhara and Gounni, 2012; Benoit et al. Under this classification system, M1 macrophages are associated with greater proinflammatory responses to encounters with intracellular antigens, while M2 macrophages are associated with greater roles in antiinflammatory responses and tissue repair. The M1/M2 classification scheme for macrophages, however, is generally considered an overly simplistic representation of macrophage populations. Studies have suggested that macrophages have great plasticity, and that there exists a wide range of proinflammatory and antiinflammatory effects bridging the M1/M2 classifications (Benoit et al. While the M1/M2 classification system is useful, there is a need to address subpopulations that are not clearly defined in this context. Mycobacterium tuberculosis, a bacterial pathogen that multiplies inside pulmonary macrophages and causes tuberculosis infection, typically results in macrophages adopting a proinflammatory M1 phenotype (Benoit et al. An impaired phagocytic response or the production of inapplicable cytokines due to incorrect macrophage polarization may result in increased and more severe infectious disease, pneumoconiosis from dust inhalation (such as silicosis due to silica inhalation), or pulmonary fibrosis. Impairment of alveolar macrophage function in smoking individuals, for example, has been shown to increase in the risk of pulmonary infection as a result of reductions in phagocytic and clearance mechanisms (Marti-Lliteras et al. Within the context of a host resistance model, if decreased antigenic clearance is observed and is related to decreased macrophage activity, the degree of macrophage functional impairment may be measured via evaluation of phagocytosis and respiratory burst activity. Species-specific differences may exist, however, as this finding regarding the effect of phosgene on influenza virus infection was not replicated in mice (Ehrlich and Burleson, 1991; Selgrade et al. It should be noted, however, that direct comparisons between the rat and mouse studies are difficult due to differences in age, as well as the dose and regimen of phosgene exposure. Following 2­4 h of incubation, the amount of label (such as 51-Cr) is determined in the supernatant, as a measure of target cell lysis. This suggests the presence of a mechanism to mediate cytotoxic and inflammatory responses, as unchecked inflammation can be detrimental to host tissues. Adaptive immunity, initiated within days of engagement by foreign antigens or infectious agents, is composed of cell-mediated (T-lymphocyte driven) and humoral-mediated (B-lymphocyte driven) immunity, resulting in lasting antigen-specific recognition and rapid protection upon pathogen re-exposure. Adaptive immune responses are delayed compared to innate immune responses, with initial activity appearing 4­7 days following pulmonary infection (Janeway et al. These cell types play a critical role in the immune response and protection against infectious disease. Such immunoregulatory cytokines and mechanisms are critical in the prevention of destructive, uncontrolled inflammation in response to immune system challenge. Such killing mechanisms are critical to clearance of intracellular and viral pathogens (Trapani and Smyth, 2002). In murine viral infection studies, the presence of virus-specific memory T cells in the local pulmonary tissue resulted in more efficient viral clearance and increased host survival upon secondary encounter with viral pathogen. Injury to or suppression of the humoral arm of the immune response results in increased susceptibility to , and decreased recovery from, infectious pathogens. Furthermore, antibody class switching may be evaluated in the serum if analysis measures both the IgM and IgG responses. Naive B cell antigen recognition may occur via thymusdependent or thymus-independent mechanisms and results in B cell activation. This innate-like response producing antibody with low antigen specificity contributes to host defense during the temporal gap between antigen encounter and the generation of a highly specific response. Signaling between T cells and B cells and activation of B cells induces intrafollicular germinal center formation, B cell expansion, somatic hypermutation of Ig variable domains, as well as class switching from IgM to IgG, IgA, or IgE. Progeny may differentiate into plasma cells, dedicated to high levels of antibody production and secretion, or memory B cells, dedicated to continuing protection against the antigen. Progenies that produce Ig with the highest antigenic affinity are selected for survival (Seagal and Melamed, 2003). Initial encounter with viral, bacterial, or fungal antigen typically induces an IgM-dominant response, important in the eradication of pathogen via neutralization and complement-mediated pathways. Secondary encounter with antigen often generates an IgG-dominant response, contributing to pathogenic clearance via phagocytosis- and opsonization-mediated pathways (Cerutti et al. Similar to memory T cells, memory B cells may survive for decades following initial antigen exposure, as noted in survivors of the 1918 influenza pandemic (Pieper et al. Memory B cells, recruited and/or locally generated following lung immunization, uphold long-term maintenance of antiantigenic antibody and confer protection against recurrent pulmonary infections (Bice and Muggenburg, 1988; Bice and Shopp, 1988; Bice et al. The importance of specific antibody responses against influenza virus infection was investigated by Ada et al. IgM antibody-secreting cells were reported in the spleen 3 days post infection and in the lung on day 5. IgG-secreting cells were observed in the spleen on day 6 post infection and in the lung on day 10 (Ada et al. The importance of antibody in defense against bacterial infection is also well characterized, as deficiencies in antibody-related mechanisms result in increased susceptibility to infection, particularly infection with encapsulated bacterial pathogens including S. Indeed, individuals with primary antibody deficiencies are at an increased risk for pneumonia and resulting complications such as chronic lung disease following infection with H. Moreover, respiratory viral infections are known to cause exacerbation of asthma in children and adults and contribute to morbidity and mortality in asthmatic patients (Tan, 2005). Another example of altered host defense due to pathogenic exposure is the observed heightened susceptibility to bacterial infection that follows influenza virus infection. Together, influenza and bacterial pneumonia are a lethal combination, contributing to morbidity and mortality worldwide. Indeed, the majority of deaths during the 1918 Spanish influenza were attributable to secondary infection with bacterial pneumonia. While the correlation between respiratory viral infection and heightened risk for subsequent bacterial infection is well known, the pathways and mechanisms involved are not well characterized (Small et al. It has been hypothesized, however, that injury to the respiratory epithelium incurred by infection with influenza may result in increased bacterial colonization due to ease of adherence to damaged cells. In addition to immunological alterations induced by pathogenic exposure, xenobiotic and toxicant exposure may induce alterations to the immune response as well. Xenobioticsdchemical agents or pollutants not naturally produced in an organismdare capable of initiating or potentiating upper and lower respiratory tract hypersensitivity disorders due to direct or indirect consequences of species-specific differences, genetics, epigenetics, or the immunome or microbiome. Thus, inflammation and lung damage related to xenobiotic exposure may affect the recruitment of immune cells and antibody from the blood to the lung. With regard to lymphocyte memory responses, decreases in antibody production by plasma cells located in the alveoli and interstitial tissues due to inhalation of xenobiotics may decrease resistance to infectious agents (Bice et al. As most of these memory cells are within the lung interstitium, they are therefore susceptible to the impacts of inhaled xenobiotics (Bice et al. These cells provide protection and local immunological memory against Host Resistance Assays for Immunotoxicity Testing 533 infectious pathogens. Therapeutics, particularly immunosuppressive and immunomodulatory drugs, induce alterations in the immune response. Not surprisingly, Infliximab has also been associated with increased susceptibility to upper respiratory tract infections (Hanauer, 1999). Cyclosporine, an immunosuppressive agent used to inhibit transplant rejection as well as excess inflammation related to rheumatoid arthritis and psoriasis, reduces T cell activation to exert its effects. Inhibition of T cell activation, however, increases susceptibility to viral infection (Graham, 1994). Natalizumab (Tysabri), a humanized monoclonal antibody prescribed for patients with relapse-remitting multiple sclerosis, targets the a4 subunit of a4b1 and a4b7 integrinda cell adhesion molecule on activated T cells and other cell types. While there are simply too many immunomodulatory and immunosuppressant therapeutics to discuss, such therapeutics should be prescribed with care. The goal of immune response modification in the treatment of immune disorders must be assessed with both risks and benefits in mind, as tapering inappropriate immune responses may also dull responses required to combat infectious disease. In fact, host resistance assays were also used as a relevant comparator in early seminal studies that evaluated various immunological assays for usefulness in predicting immunotoxicity for risk assessment (Luster et al. Host resistance assays utilize a fully integrated immune system where it is possible to determine if a test material adversely affects the development of immunity to infectious agents or immune surveillance for neoplastic cells. While tumor animal models are widely used in determination of efficacy, syngeneic murine tumor host resistance models have also been used to determine if exposure to chemicals or toxicants results in changes in tumor susceptibility (Ng et al. However, the more common host resistance models used for immunotoxicity testing involve an infectious agent. In this integrated response, effects on a particular cell type or function may be offset by other components of the immune system, so that the host is still able to clear the infection. In this case, the remaining functional components of the immune response provide the immunological reserve required to successfully eliminate the infection. In other cases, a number of small defects in multiple immune functions or pathways may impair the immunological reserve and increase the severity of the infection. In either case, host resistance assays allow the evaluation of the net result of an effect/effects on immunological reserve. In addition, host resistance assays can also provide valuable insights into possible mechanism(s) underlying the adverse effect, when alterations related to specific endpoints. Host resistance studies with infectious agents have previously used mortality as an endpoint. With increased concern for animal welfare and the emphasis on the 3Rs, these models have been refined to use alternate endpoints. Challenge in excess with a high titer of the infectious agent or with an extremely virulent agent overwhelms the immune system and may be more reflective of a model of sepsis or "cytokine storm" rather than a model for immunotoxicity evaluation. Immunological clearance of the infectious challenge agent and evaluation of the infectious burden are therefore considered more sensitive and meaningful measures of immunological function than mortality (Burleson, 1995; Lebrec and Burleson, 1994; Selgrade and Daniels, 1995). When selecting host resistance models, the emphasis should not be placed on the particular viral, bacterial, fungal, or parasitic agent that provides the infectious challenge, but rather on how the immune system responds to challenge with a natural antigen. Host resistance assays may be classified as comprehensive host resistance assays or targeted host resistance assays, with comprehensive host resistance assays providing an evaluation of the overall health of the immune system, and targeted host resistance assays designed to better evaluate specific immunotoxicity concerns (Table 1). While comprehensive host resistance assays such as the influenza host resistance assay are used to assess the overall health of the immune system, targeted host resistance models are used to address questions regarding the nature of a potential immune defect. Questions regarding specific immune concerns may arise from results of screening or functional assays or from potential specific immune liabilities related to test articles with a similar chemical structure or mechanism of action. Targeted host resistance assays allow a determination of whether the specific immune deficit of potential concern is, in fact, adverse. Namely, does a percent decrease in a given immunological parameter result in decreased clearance of the infectious agent The influenza virus host resistance model in mice and rats does not cause mortality and is perhaps one of the most thoroughly characterized host resistance models. This model recapitulates a nonlethal influenza infection in an intact and functional immune system, incorporates a cascade of immune responses to the virus challenge, and provides a measure of the health of the immune system. Mechanistic immune function endpoints can be incorporated and measured alongside viral clearance and may include measures of nonspecific immunity. Histopathology, hematology, and immunophenotypic evaluation of cell subsets can be incorporated in the host resistance study to provide additional mechanistic insights. The reovirus host resistance model has been used to evaluate the immunotoxic effects of cyclophosphamide (a model immunosuppressive compound) on intestinal immune responses (Cuff et al. Clearance of the virus as well as induction of reovirus-specific intestinal IgA, serum IgG, cell-mediated responses, and cytokine responses have been evaluated in the intestinal mucosa and gutassociated lymphoid tissue of mice (Cuff et al. Viral infections can be lytic, with release of the progeny virus resulting in lysis of the host cell, or latent, where the virus is quiescent and not actively replicating. Persistent infections contain a combination of these processes where there are stages of both active infection and latency. Reactivation of viral Host Resistance Assays for Immunotoxicity Testing 535 infections results from a variety of internal and external factors that cause the latent virus to switch to active lytic replication. Many viruses capable of latent virus reactivation are ubiquitous in the human population, cause a mild primary infection that is followed by latency, and where immunosuppression results in reactivation of the latent virus. Mouse and rat cytomegalovirus viral host resistance models can be used to evaluate immunotoxicity (Selgrade and Daniels, 1995) and (Garssen et al. Following confirmation of latency, the animals are dosed with the agent of interest to determine if treatment results in recrudescence of the viral disease and measurable lytic virus. Macrophages and neutrophils are important innate immune cells that are involved in the clearance of Streptococci from the lungs of mice and rats (Gilmour et al. In this host resistance model, rodents are anesthetized and infected intranasally with a sublethal inoculum of S. Bacterial clearance is measured in the lungs of infected animals at several time points within 48 h of infection, which is prior to development of adaptive immune responses in the lung (Burleson and Burleson, 2006; Gilmour et al. Dexamethasone and cyclophosphamide have immunosuppressive effects on innate immunity and reduce bacterial clearance and can be used as positive immunomodulatory controls in this model. During the performance of the host resistance assay, other endpoints may be incorporated as mechanistic probes for observed immunotoxicity. Flow cytometric evaluation of immune cells and macrophage and/or neutrophil function assays may be performed to determine if there were adverse effects on cell number or function. Antiinflammatory agents, while important to human health, are known to be immunosuppressive. This ability to rank-order innate immune suppressive effects of multiple agents in a single study further enhances the utility of this model as a potential screen for drug candidates. It is an important cause of Gram-negative infections especially in immunocompromised patients and also causes diseases of the urinary tract, skin, blood (bacteremia), abscesses, eye infections, meningitis, and endocarditis.

Syndromes

• You take certain anti-seizure or blood thinning drugs
• Insect bites and stings
• Anxiety
• Subacute thyroiditis
• The compulsion to repeatedly wash the hands to ward off infection
• Knee swelling
• Kidney scan

Bioavailability the degree to which a drug or other substance becomes available to the target tissue after administration erectile dysfunction doctors fort worth cheap tadora 20 mg on line. Carnitine A betaine derivative involved in the transport of fatty acids into mitochondria impotence hypertension medication discount 20 mg tadora with amex, where they are metabolized erectile dysfunction statistics in canada 20 mg tadora order visa. Conjugation the joining together of two compounds to produce another compound erectile dysfunction protocol ebook generic 20 mg tadora with visa, such as the combination of a toxic product with some substance in the body to form a detoxified product erectile dysfunction tampa purchase online tadora, which is then eliminated. Constitutive Produced constantly or in fixed amounts, regardless of environmental conditions or demand. Coproporphyrinuria the presence of excess coproporphyrin (a nitrogenous organic substance normally excreted in the feces as a breakdown of bilirubin) in the urine. Downregulation the process that decreases ligand and receptor interactions or reduces the responsiveness of a cell to a stimulus following first exposure. Drug interaction A chemical or physiologic reaction that can occur when two different medications are taken together and the interaction may affect the metabolism, effectiveness, or toxicity of the other. Electrogenic Refers to a substance that contributes to an electrical potential across a membrane. Encephalopathy Degeneration of brain function, caused by any of various acquired disorders, including metabolic disease, organ failure, inflammation, and chronic infection. Endogenous Developing or originating within the organisms or arising from causes within the organism. Enhancer A nucleic acid sequence that increases the transcription or utilization of a gene. Ergothioneine the betaine of a sulfur-containing derivative of histidine, present in blood and other mammalian tissue and in ergot. Facilitated diffusion Carrier-mediated transport of a noncharged molecule down its chemical gradient via a specific membrane-integrated protein. Genome-wide association study An examination of many common genetic variants in different individuals to see if any variant is associated with a trait. Genotype the combination of alleles located on homologous chromosomes that determines a specific characteristic or trait. Reduced glutathione is important in protecting erythrocytes from oxidation and hemolysis; deficiency causes sensitivity to oxidant drugs. Glycosylation the addition of saccharides to proteins or lipids to form a glycoprotein or glycolipid. Homeostasis A tendency to stability in the normal body states (internal environment) of the organism. Homology Two structures or traits within different organisms which originated from a structure or trait of their common ancestral organism. Hydrolysis the splitting of a compound into fragments by the addition of water, the hydroxyl group being incorporated in one fragment and the hydrogen atom in the other. Hydrophilic Pertaining to the property of attracting or associating preferentially with water molecules, a quality possessed by polar radicals or ions. Hydrophobic Pertaining to the property of repelling or preferentially excluding water molecules, a quality possessed by nonpolar radicals or molecules that are more soluble in organic solvents than in water. Symptoms include subnormal temperature, weak pulse, gastroenteric symptoms, encephalopathy, and coma. Symptoms include cold and pale skin, numbness around the mouth, apprehension, heart palpitations, emotional outbursts, hand tremors, mental cloudiness, dilated pupils, sweating, and fainting. Immunoprecipitation the separation of an antigen from a solution by the formation of a large complex with its specific antibody. In silico analysis Analysis performed using computers in conjunction with informatics capabilities. Induction the relief of repression for a gene or set of genes under negative control by a repressor. Isoform A protein having the same function and similar (or identical sequence), but the product of a different gene and usually tissue specific. Linkage disequilibrium the occurrence of some genes together, more often than would be expected. Lipophilic Having an affinity for fat, pertaining to or characterized by lipophilia. Multimer A structure composed of several identical or different subunits held together by weak bonds. Myristoylation An irreversible, co-translational (during translation) protein modification found in animals, plants, fungi, protozoans, and viruses. In this protein modification, a myristoyl group (derived from myristic acid) is covalently attached via an amide bond to the alpha-amino group of an N-terminal amino acid of a nascent polypeptide. Nuclear receptor Any of a "superfamily" of soluble (nonmembrane-bound) receptors for a constellation of physiologically active compounds (ligands), such as retinoids, steroids, thyroid hormone, vitamin D, and hypolipidemic drugs. Odds ratio A measure of effect size, describing the strength of association or nonindependence between two binary data values. Oligonucleotide Linear sequence of up to 20 nucleotides joined by phosphodiester bonds. Ortholog A homologous sequence found in different species and derived from a common ancestor. Oxidation the combination of a substance with oxygen; a reaction in which the atoms in an element lose electrons and the valence of the element is correspondingly increased. Uptake Transporters 577 Pharmacodynamics the study of the biochemical and physiological effects of drugs and the mechanisms of their actions, including the correlation of their actions and effects with their chemical structure. Pharmacogenetics the study of the relationship between genetic factors and the nature of responses to drugs. Pharmacokinetics the action of drugs in the body over a period of time, including the processes of absorption, distribution, localization in tissues, biotransformation, and excretion. Phenotype the entire physical, biochemical, and physiological makeup of an individual as determined both genetically and environmentally. Phosphorylation the metabolic process of introducing a phosphate group into an organic molecule. Polymorphism the regular and simultaneous occurrence in a single interbreeding population of two or more alleles of a gene, where the frequency of the rarer alleles is greater than can be explained by recurrent mutation alone (typically > 1%). Prostaglandin Any of a group of potent hormone like substances that are produced in various mammalian tissues, are derived from arachidonic acid, and mediate a wide range of physiological functions, such as control of blood pressure, contraction of smooth muscle, and modulation of inflammation. Quaternary structure the arrangement of separate polypeptide subunits in the structure of a multimeric protein. Recessive Of, relating to , or being a trait expressed only when the determining allele is present in the homozygous condition. Regulation the adaptation of form or behavior of an organism to changed conditions. Often the result of electrical injury, alcoholism, injury (or laying in one position for an extended period of time), drug side effects or toxins. Stools may also float (due to excess gas from carbohydrate malabsorption), have an oily appearance or be foul smelling. There is increased fat excretion, which can be measured by determining the fecal fat level. While definitions have not been standardized, fat excretion in feces in excess of 0. Stereospecific Exhibiting marked specificity for one of several stereoisomers of a substrate or reactant; said of enzymes or of synthetic organic reactions. Stoichiometry the calculation of quantitative (measurable) relationships of the reactants and products in chemical reactions (chemical equations). Symporter An integral membrane protein that is involved in active transport of two or more different molecules or ions across a phospholipid membrane such as the plasma membrane in the same direction. Topology Describes which portions of the amino acid sequence of the protein lie within the plane of the surrounding lipid bilayer and which portions protrude into the watery environment on either side. Transporter Proteins that go completely through a cell membrane and carry specific drugs, hormones, nutrients, ions, etc. Uniporter A protein that mediates the transport of one molecule or ion through a membrane without known coupling to the transport of any other molecule or ion. Xenobiotic A chemical which is found in an organism but which is not normally produced or expected to be present in it. Zwitterion A chemical compound that is electrically neutral but carries formal positive and negative charges on different atoms. Transporter proteins can be generally separated into two major classesduptake Uptake Transporters 579 and efflux transporters. Some facilitate the cellular entry of solutes or substrates while others prevent their entry. Not only are transporter proteins critical to human physiology in the maintenance of normal homeostasis via transport of endogenous substrates, but they are also, in many cases, important to the disposition of numerous xenobiotic compounds such as environmental toxins, dietary constituents, drugs, and their metabolites. In particular, the study of drug transport across biological membranes has garnered considerable attention over the last two decades as a result of rapid advances in genetic, molecular, biological, pharmacologic, and computational tools that have delineated the emerging functions of the responsible transporter proteins. The goal of this article is to summarize the current state of knowledge in the area of uptake transporters and their relevant roles in normal physiology and xenobiotic disposition. As the name suggests, uptake transporters facilitate the movement of drugs into cells. We will begin with a review of nomenclature followed by sections covering gene organization, aspects of gene expression and regulation, relevant polymorphic variants, protein structure, transport mechanisms, substrate specificity, physiological and clinical relevance. For the Oatps, the italicized gene symbol begins with Slco while the encoded proteins are named with the root Oatp. Specific transporter proteins are then given numerical designation after the subfamily heading. The final numeral is named chronologically and allows for unambiguous identification of Oatp transporters between species. While these transporters demonstrate generalized selectivity in the types of substrates they transport, they share a common characteristic of being polyspecific in their capacity to accept compounds with different sizes and molecular structures. Paired genes tend to be coexpressed and exhibit the most homology suggesting a common regulatory mechanism for expression and an evolutionary duplication event as the origin of pairing (Eraly et al. Despite possessing similar genomic organization, they only share 35% amino acid sequence identity (Oelkers et al. Part of the Asbt transcript undergoes exon skipping, resulting in a frameshift and shortened protein product containing 154 instead of 348 amino acids. T-Asbt appears to be functional as it has been localized to the basolateral membrane of cholangiocytes and shown to mediate bile acid efflux (Lazaridis et al. These domains participate in a coordinated series of signaling events to promote the initiation of target gene transcription. Hnf1aÀ/À mice have hepatic dysfunction resulting from dysregulation of bile acid and cholesterol homeostasis (Pontoglio et al. Disrupted bile acid transport is associated with marked downregulation and changes in the hepatic expression of Oatps such as Oatp1a1, Oatp1a5, Oatp1b2, and Oatp2b1 (Shih et al. The expressed level of rat Oct2, but not Oct1 or Oct3, in the kidney was significantly higher in males than females (Urakami et al. Gonadectomy in male rodents reduced kidney Oct2 expression to levels comparable with that in sham-operated female mice and rats (Slitt et al. Treatment of gonadectomized male and female mice with 5a-dihydroxytestosterone induced renal Oct2 in both sexes (Alnouti et al. In addition, treatment of intact male and female rats with testosterone significantly increased rat Oct2 expression in the kidney (Urakami et al. Collectively, these data suggest that testosterone plays an important role in the transcriptional regulation of the rat Slc22a2. Furthermore, functional reporter analyses of rat Slc22a1-3 genes coexpressed with the androgen receptor were performed in an effort to elucidate the role of testosterone in gender-specific differences in renal Oct2 expression (Asaka et al. In rats, physiologic concentrations of testosterone ($10 nM) specifically induced transcription of Slc22a2, but not of the Oct1 or Oct3 gene, apparently via interactions with androgen response elements in the rat Oct2 promoter. Within the past two decades, with significant improvements in sequencing technology. However, for the most part, studies relating to transporter pharmacogenetics have only recently become available. Nevertheless, the clinical relevance of genetic heterogeneity in transporter genes continues to be actively and vigorously assessed by various research groups with particular attention to interindividual variability in drug disposition. The effect of genetic variations on the transport-mediated hepatocellular uptake of statins has been extensively investigated. Further studies are required to clarify the mechanisms responsible for these in vivo observations. Increased systemic drug exposure is a risk factor for statin-mediated myopathies including severe rhabdomyolysis (Thompson et al. In another study, hepatic cholesterol synthesis was assessed in healthy subjects administered with multiple-dosing pravastatin by measurement of plasma cholesterol and lathosterol concentrations (Niemi et al. Using Oatp1a/1bÀ/À and Abcc3À/À mice, the authors determined that Abcc3 secretes bilirubin conjugates into the blood, while Oatp1a/1b transporters mediate their hepatic reuptake. This is consistent with Oatp1a/1bÀ/À mice which display marked conjugated hyperbilirubinemia (van de Steeg et al. Interestingly, imatinib transport mediated by the 404A>T, 516A>C, and 559G>A variants was significantly impaired in vitro (Eechoute et al. The biguanide metformin is widely used as a first-line therapy for the treatment of type 2 diabetes (Kirpichnikov et al. Moreover, compared with wild-type mice, Oct1À/À mice have reduced metformin distribution to the liver (Wang et al. Four of the variants, including Ser14Phe, Ser189Leu, Gly401Ser, and 420del demonstrated significantly reduced Vmax values compared to the reference wild-type protein.

This evaluation is made by comparing the antibody response in animals administered with test material verses control animals including its kinetics erectile dysfunction caused by radical prostatectomy buy 20 mg tadora with visa, magnitude erectile dysfunction caused by supplements discount tadora 20 mg without a prescription, and the observation of class switching when applicable best rated erectile dysfunction pills cheap 20 mg tadora fast delivery. Due to the variable nature of a "normal" immune response from individual to individual (animal or human subjects) erectile dysfunction of diabetes generic tadora 20 mg overnight delivery, a statistical signal at an isolated time point may not necessarily be a concern erectile dysfunction meds online discount 20 mg tadora with visa. Biological plausibility must also be considered in the context of the nature of the response, and evidence of overt multisystem toxicity may signify that effects on the immune system are mediated by stress and/or secondary to other effects rather than direct immunotoxicity. Although this descriptive data does not evaluate immune function, it may provide an indication of immune system effects. This weight-of-evidence approach allows for an overall interpretation of an immunotoxic effect that considers all available toxicity data. Abnormal antibody responses to fX174 are observed not only in patients with a B-cell defects such as X-linked agammaglobulinemia, but also in those with a T-cell defect. Patients with early complement component deficiency also have a defective antibody response to fX174 (Ochs et al. Like many other assays, it can be associated with significant interindividual variability, and it is impacted by multiple parameters such as antigen dose. It is therefore critical to carefully design studies where it is implemented and to utilize well-controlled analytical methods. The assay has been traditionally used to assess the risk or level of test-article-related immunosuppression. With the increased development of immunotherapies aimed at increasing immune responses. Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial. Immune parameters are affected differently after cyclosporine A exposure in Fischer 344 rats and B6C3F1 mice: implications for immunotoxicology. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: A workshop summary. Effects of ustekinumab administration on primate/human antigen-recall and humoral immune response functions. Correction of equine severe combined immunodeficiency by bone marrow transplantation. Nonclinical Safety Assessment: A Guide to International Pharmaceutical Regulations (3rd Edition). Proceeding of the Society of Experimental Biology and Medicine, 122(4), 1167­1171. Assessment of immunobiological effects induced by chemicals, drugs or food additives. Cutting Edge: Critical role of inducible costimulatory in germinal center reactions. Interpreting stress responses during routine toxicity studies: A review of the biology, impact, and assessment. Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Identification and characterization of keyhole limpet hemocyanin N-glycans mediating crossreactivity with Schistosoma mansoni. Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation. Schistosoma mansoni shares a protective carbohydrate epitope with keyhole limpet hemocyanin. Chronic administration of Belatacept, a T-cell costimulatory signal blocker, in cynomolgus monkeys. Harmonised tripartite guideline: Immunotoxicity studies for human pharmaceuticals S8. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Evaluation of canine T-cell dependent antibody response to the primary and secondary immunization with keyhole limpet hemocyanin. Evaluation of primary and secondary responses to a T-cell-dependent antigen, keyhole limpet hemocyanin, in rats. Combined analysis of heterogeneous immunotoxicology studies using functional T cell-dependent antibody response tests. T-Cell-Dependent Antibody Response Assay: Biology, Methods, and Application 397 Krueger, J. Immunological investigation using pharmaceutical drugs: In vivo evaluation of immune effects. An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: T-cell-dependent antibody responses. T-cell-dependent antibody responses in the rat: Forms and sources of keyhole limpet hemocyanin matter. The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: Study design, data analysis, interpretation. Tofacitinib suppresses antibody responses to protein therapeutics in murine hosts. Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies. Assessing a theoretical risk of Dolutegravir-induced developmental immunotoxicity in juvenile rats. Immune responses in adult female volunteers during the bed-rest model of spaceflight: antibodies and cytokines. Comparison and characterization of immunoglobulin G subclasses among primate species. Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses. Helper T-cell subsets: Phenotype, function and the role of lymphokines in regulating their development. Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: A randomized, open-label, parallel group study in healthy subjects. Effects of toxaphene on the immune system of cynomolgus (Macaca fascicularis) monkeys. The primary and secondary antibody response to bacteriophage phi X 174 in guinea pigs. Assessment of Hepatitis B surface antigen and tetanus toxoid-specific T cell-dependent antibody responses in cynomolgus monkeys. The recognition and classification of immunodeficiency diseases with bacteriophage phi Chi 174. Preclinical safety evaluation of biopaharmaceuticals: A science-based approach to facilitating clinical trials. Principles and methods for assessing direct immunotoxicity associated with exposure to chemicals. A report of the International Programme on Chemical Safety (Environmental Health Criteria 180). Assessment of the functional integrity of the humoral immune response: the plaque-forming cell assay and the enzyme-linked immunosorbent assay. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time post-transplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. United States Department Of Health And Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Molecular Biology Branch, Division of Life Sciences, Office of Science and Technology. Each cell type expresses different markers, and those markers can be used to differentiate between them. While immunophenotyping is typically used to identify subpopulations of peripheral blood cells, it can also be used on solid tissues such as the spleen and lymph nodes. Basic principles and methods of flow cytometry are discussed in this book chapter. In general, if a single-cell suspension can be obtained, cells can be identified using flow cytometry. Over the years, immunophenotyping has proven useful in basic research, clinical medicine, and drug development. Applications include the diagnosis of hematologic malignancies and assessment of the potential adverse effects of drugs on the immune system in nonclinical toxicology studies. Immunophenotyping permits a more in-depth assessment of cell types than can be accomplished with a hematologic assessment. While a typical hematology report provides quantitative information on the components of blood, such as white blood 399 400 Immunophenotyping in Drug Development cells, neutrophils, lymphocytes, monocytes, eosinopils, basophils, and red blood cells, immunophenotyping provides information on subsets of cell types. For example, subsets of lymphocytes include natural killer cells, B-cell lymphocytes, and T-cell lymphocytes. An assessment of cell subsets allows the identification of subtle changes to the immune system that may be undetectable by a less specific hematology measurement. For example, a shift in T-cell populations from cytotoxic Tcells to memory T-cells can be detected by immunophenotyping but not by hematology. A cell-type shift may be directly related to the function of the drug and thus serve as a biomarker of pharmacology. If a cell-type shift is related to drug toxicity, it may be a toxicologic biomarker. In this book chapter, standard immunophenotyping is described, as well as less common assays incorporated in nonclinical studies, which are often used to monitor the pharmacodynamic effect of drugs, for identifying small cell populations or for assessing specific cell functions. Common protocols used for immunophenotyping in nonclinical studies will be described, along with some of the most standard markers included in nonclinical studies. Data analysis and presentation, as well as regulatory perspective on immunophenotyping and its role in drug development, will also be covered. It is a laser-based technology that analyzes multiple characteristics of a single particle (usually cells). It allows multiparametric analysis of thousands of particles per second and helps to adequately identify, enumerate, or functionally characterize complex cell populations of interest. It can be used for immunophenotyping of a variety of specimens, including whole blood, bone marrow, and solid tissues. To accomplish this, flow cytometers employ the coordinated use of three components: the fluidics, optical, and electronic systems (Shapiro, 2003). The fluidics system transports particles in a stream to the laser beam for interrogation; the optics system consists of lasers to illuminate the particles in the sample stream, and optical filters to direct the resulting light signals to the appropriate detectors; the electronics system converts the detected light signals into electronic signals that can be processed by the computer. Inside a flow cytometer, cell suspensions are drawn into a stream created by sheath fluid, allowing the cells to pass individually in front of a laser. The scattered and fluorescent light is collected by appropriately positioned lenses and detectors. The detectors produce electronic signals that are captured by and stored in a computer. Over the last 60 years, flow cytometry and cell sorting platforms have benefitted from developments in the area of optics, particularly in laser light sources, and electronics. This has reduced costs, increased flexibility, decreased space requirements, and simplified operations. These are some of the reasons why flow cytometry is now widely used and seen as a versatile technology for drug development. In the discovery space, flow cytometry technology can be used to screen drug candidates for changes in immunophenotype or cell function using ex vivo or in vivo designs. Plate-format assays requiring only small amounts of samples and/or drugs can be developed, using multicolor fluorescence and high-throughput acquisition. During the nonclinical phase, flow cytometry has routinely been used for assessing the potential immunotoxicology of a drug candidate by evaluating the immunophenotype of various cell populations in whole blood, tissue, or other matrices in the context of the overall nonclinical study. In a clinical setting, flow cytometry can be used for monitoring changes in immunophenotype related to toxicity or to pharmacodynamics. While changes in cell phenotypes are useful in some settings to characterize the immunotoxicity of different compounds, immunophenotyping alone is not always a sensitive indicator of low-dose immunotoxicity for agents that modulate immune functions. Although compounds that induce selective toxicity on lymphoid and myeloid cells may be discovered through immunophenotypic analysis, some agents produce changes in cell populations by redistribution or stimulating shifts in the proliferation of cell subtypes at doses much lower than those required to produce cytotoxicity. However, immunophenotyping cannot identify all forms of immunotoxicity; some of the most potent immunosuppressive chemicals that have been tested, such as cyclosporine A, do not alter the number of cells/immunophenotype at doses that are immunosuppressive and cause the immune cell function to be altered (House et al. In these cases, immunophenotyping should be assessed in conjunction with functional parameters such as cytotoxic T-cell or natural-killer cell activity, or T-cell-dependent antibody response assays to identify the immunotoxic effects. In some instances, immunophenotyping may also be used as a pharmacodynamic endpoint. Indeed, some drugs, such as rituximab, are designed specifically to deplete lymphocyte populations. In such cases, immunophenotyping is a sensitive endpoint with which to monitor the efficacy of the drug. For example, regulatory T-cells (Tregs) represent only 1­2% of total lymphocytes in peripheral blood, but these cells serve a vital immunosuppressive function. Expression of many adhesion molecules and growth receptors altered on leukocytes during cell activation and differentiation may also help to identify the specific activation state of small or larger cell populations following exposure to a drug. Many of these molecules are lineage associated and can be used to identify subsets, as well as altered expression following exposure to drugs. Other markers of cell activation and proliferation that are being used with increasing frequency include various cytokine and chemokine receptors and proliferating cell antigens such as Ki67 protein. The use of fluorophore-labeled streptavidin for tetramer formation allows for efficient detection by flow cytometry.

Further studies need to be conducted with a system that can bioactivate drugs or with in vivo models erectile dysfunction 30 20 mg tadora with mastercard. Exosomes are initially present inside large multivesicular endosomes within a cell; however erectile dysfunction vasectomy tadora 20 mg buy amex, endosomes can fuse with the plasma membrane and then release these exosomes into the extracellular environment (Pan et al erectile dysfunction treatment guidelines purchase tadora overnight delivery. This suggests intercellular communication can occur by the transfer of macromolecules through exosomes erectile dysfunction drugs available over the counter discount tadora 20 mg buy line. Exosomes can cause receptor­ligand interactions by transporting a ligand from one cell to a recipient cell (Raposo et al how is erectile dysfunction causes buy discount tadora 20 mg line. In vitro models studying the release of exosomes generally involve primary cell cultures or cell lines. However, many cell types can be used depending on the hypothesis being tested, because exosomes are shed from almost every cell type. There are other attempts to use exosome release as a general biomarker of drug-induced liver injury (Yang et al. Even relatively simple parameters such as covalent binding are often quite different in vitro than in vivo. Therefore, it is important to reproduce what happens in humans in an animal model so that it can be carefully studied and multiple variables can be controlled. For example, it was shown that amodiaquine caused acute liver injury in mice, but it was only significant if glutathione was depleted (Shimizu et al. Specifically, it is acute rather than delayed, and it is characterized by a hepatic infiltration of neutrophils rather than mononuclear leukocytes. In addition, it is positive with ranitidine, which is a safe over-the-counter drug; therefore, if it were used to screen drugs, it would eliminate safe drugs. We found that it also causes a skin rash in rats, especially Brown Norway rats (Shenton et al. The rash is immune mediated and has features similar to the rash in humans (Shenton et al. Using this model we were able to demonstrate that the rash is caused by a reactive sulfate conjugate formed in the skin from an intermediate benzylic alcohol metabolite formed in the liver (Sharma et al. In particular, we were able to block covalent binding in the skin and the skin rash with the topical administration of a sulfotransferase inhibitor. We were unable to develop a mouse model of nevirapine-induced skin rash, and we found that there is no covalent binding of nevirapine in the skin of mice; they do not appear to have the requisite sulfotransferase to bioactivate the nevirapine metabolite. However, this strategy did not work, and most of these studies were never published. We also tried to increase reactive metabolite formation or decrease detoxification through depletion of glutathione or ascorbate (Ip et al. Cancer cells often express proteins not present on normal cells, and to evade destruction by the immune system, they must induce immune tolerance. Antibodies called checkpoint inhibitors were developed to block these molecules, and they have had remarkable success in the treatment of some cancers such as melanoma (Callahan and Wolchok, 2013). We subsequently used this model with other drugs and found that it unmasked the potential of isoniazid and nevirapine to cause liver injury, although the injury was milder than with amodiaquine (Mak and Uetrecht, 2015c). This model has the potential to finally permit rigorous testing of mechanistic hypotheses. Boelsterli found that mice that were heterozygous deficient in mitochondrial superoxide dismutase-2 developed mild delayed onset liver injury when treated with troglitazone, but the wild type animals did not (Ong et al. It appears that there were other mutations in the strain of mouse that Boelsterli used that also contributed to the liver injury. It also causes a lupus-like autoimmune reaction that appears to be specific to Brown Norway rats (Donker et al. This leads to an immune response that is mediated, at least in part, by Th17 cells (Zhu et al. In contrast, treatment of Brown Norway rats with a low dose of penicillamine led to immune tolerance that could be transferred to naïve rats with spleen cells and protect them penicillamineinduced autoimmunity. This led to an animal model of propylthiouracil-induced autoimmunity (Aucoin et al. However, when we tried further experiments with this model, we were unable to reproduce it. It is especially difficult when the incidence of an idiopathic disease is more common than the drug-induced form such as in the case of aplastic anemia. The lymphocyte transformation and related lymphocyte activation tests are useful when positive; however, they are often falsely negative, and they require either fresh or carefully cryopreserved cells and significant experience in performing the assay. However, such algorithms do not offer much flexibility, and a panel of experts is considered to be more accurate at causality assessment (Watkins, 2015). In some cases, a patient may be taking several drugs, and it can be difficult to know which, if any, is responsible for a given adverse event. Mechanistic studies are very difficult to perform and little is known with certainty about their mechanisms. However, most patients do not have the same degree of impaired immune tolerance as these animal models. The principle of heterologous immunity implies that there need not be structural similarity between the pathogen and the drug-modified protein in order for the pathogen to shape the immune response so that it responds strongly to an immunogen produced by the drug. In addition to small molecules, there are a large number of biologics that are designed to modulate the immune response. Some dampen the immune response to treat immune-mediated diseases and others are designed to stimulate the immune system or impair immune tolerance to treat cancer. However, the new animal models based on impaired immune tolerance should make it possible for the first time to perform controlled mechanistic studies. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. Liver safety assessment: Required data elements and best practices for data collection and standardization in clinical trials. Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma. Preservation of basophils in dapsone-induced agranulocytosis suggests a possible pathogenetic role for leucocyte peroxidases. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma. The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice. The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury. Characterization of uptake of steroid glucuronides into isolated male and female rat hepatocytes. The unique immunobiology of the skin: Implications for tolerance of vascularized composite allografts. Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment. Genetic determinants of anti-thyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Recent advances in biomarkers and therapeutic interventions for hepatic drug safetydFalse dawn or new horizon. Functional specialization of skin dendritic cell subsets in regulating T-cell responses. Exosome: From internal vesicle of the multivesicular body to intercellular signaling device. A mechanistic approach to understanding species differences in felbamate bioactivation: Relevance to drug-induced idiosyncratic reactions. Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Enhanced anti-genicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis. The importance of hapten-protein complex formation in the development of drug allergy. Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo. A comparison of the covalent binding of clozapine, procainamide, and vesnarinone to human neutrophils in vitro and rat tissues in vitro and in vivo. Trifluoroacetylation potentiates the humoral immune response to halothane in the guinea pig. Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. A prospective clinical study of isoniazid-rifampicin-pyrazinamide-induced liver injury in an area endemic for hepatitis B. Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: A scientific review. Identification of a reactive metabolite of terbinafine: Insights into terbinafine-induced hepatotoxicity. Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases. The road less traveled by: the role of innate immunity in the adaptive immune response. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Potentially reactive cyclic carbamate metabolite of the antiepileptic drug felbamate produced by human liver tissue in vitro. Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes. Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Drug-induced liver injury through mitochondrial dysfunction: Mechanisms and detection during preclinical safety studies. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. The rational use of potentially hepatotoxic medications in patients with underlying liver disease. Covalent binding of penicillamine to macrophages: Implications for penicillamine-induced autoimmunity. Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells. Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin. Autoxidative formation of a chemically reactive intermediate from amodiaquine, a myelotoxin and hepatotoxin in man. Immunization with amodiaquine-modified hepatic proteins prevents amodiaquine-induced liver injury. When can patients with potentially life-threatening adverse effects be rechallenged with clozapine Diagnostic value of specific T-cell reactivity to drugs in 95 cases of drug induced liver injury [see comments] Gut, 41, 534­540. Investigation of the involvement of macrophages and T-cells in D-penicillamine-induced autoimmunity in the Brown Norway rat. Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes. Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: Humans are more like mice than rats. Paradoxical attenuation of autoimmune hepatitis by oral isoniazid in wild-type and N-acetyltransferase-deficient mice. Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure. Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical patterns, diagnostic considerations, etiology, and therapeutic management. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Characterization of peroxidases expressed in human antigen presenting cells and analysis of the covalent binding of nitroso sulfamethoxazole to myeloperoxidase. Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Proceedings of the National Academy of Sciences of the United States of America, 109, 9959­9964. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes.

Purchase tadora overnight delivery. "Revenge Porn" : une élue démissionne.

References

• Gomez Portilla A, Cendoya I, Uzquiza E, et al: Giant perineal hernia: Laparoscopic mesh repair complemented by a perineal cutaneous approach. Hernia 13:199, 2010.
• Kirsch AJ, Perez-Brayfield M, Smith EA, et al: The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter, J Urol 171(6 Pt 1):2413n2416, 2004.
• Simon R. Genomic driven clinical trials in oncology. Annals of Internal Medicine 2016;165(4):270-278.
• Goluboff ET. Exisulind, a selective apoptotic antineoplastic drug. Expert Opin Investig Drugs. 2001;10(10):1875-1882.
• Miettinen M, Makhlouf H, Sobin LH, et al. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol. 2006;30:477-489.
• Cruccu G, Aziz TZ, Garcia-Larrea L, et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol. 2007;14(9): 952-970.
• Prasse A, Pechkovsky DV, Toews GB, et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.